Portola has been acquired by Alexion Pharmaceuticals, Inc.

Logo for Alexion a global biopharmaceutical focused on serving patients affected with rare diseases

Portola has been acquired by Alexion Pharmaceuticals, Inc.

Learn More

  • For US Healthcare Professionals

Providing Access and Education for the Information You Need

Information on Coding, Billing and Reimbursement to help patients with access to Portola medicine.

Request Support

Build your understanding of reimbursement submissions

About PAN

Explore the educational tools and live support options available.

Learn More

Resources

Download helpful documents with practical tips.

Go to Resources
Multi-sectioned half-circle showing reimbursement support topics circling Portola Access Navigator hub
×

You are about to leave PortolaAccess.com

By clicking “Continue” below, you will transfer to another Portola website. Please note that the privacy policy and security practices may differ from those of the Portola Access site.

To stay on the current website, click "Cancel." Click "Continue" if you wish to continue on to the website you clicked on.

Continue Cancel